The receptor activator of nuclear factor kappa-B (RANK) and its ligand (RANKL) axis play major roles in breast carcinogenesis, the remodeling of the cancer microenvironment, and the suppression of the immune system [79]. Here, TNFRSF11A is linked to neoplasm.